Drug Profile
MK 0736
Alternative Names: MK0736Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Merck & Co
- Class Antihypertensives
- Mechanism of Action 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 05 Aug 2009 Phase-II clinical trials in Hypertension in Australia (PO)
- 05 Aug 2009 Phase-II clinical trials in Hypertension in European Union (PO)
- 05 Aug 2009 Phase-II clinical trials in Hypertension in Hong Kong (PO)